Viking Weight Loss Drug Shocks Industry with 6.8% Weight Reduction in 28 Days
At Viking's ObesityWeek conference on Sunday, data from a study got a lot of attention. The early study, which included 92 participants, showed that those who took a 100 mg dose of Viking tablets lost an average of 6.8 percent of their body weight in just 28 days. This result not only exceeded expectations, but also exceeded the results of competing experimental treatments. In contrast, those taking a placebo lost an average of 1.4 percent of their body weight.
Bloomberg analyst Michael Shah further noted in a note that the pill was well tolerated, with few side effects and only mild nausea, and patients did not need to stop taking it. These positive study results indicate that Viking is on track to enter mid-stage trials in the fourth quarter.
Meanwhile, Astrazeneca also presented its findings at the ObesityWeek conference on Monday, November 4. In an earlier study of 72 people, it was found that patients lost an average of 5.8 percent of their body weight after taking the pill orally and following four weeks of treatment. The oral pill, called AZD5004, mimics a gut hormone called GLP-1 to effectively control blood sugar and suppress appetite. The trial showed no serious side effects in patients with doses up to 50 mg.
Viking shares have risen more than 290% so far this year, largely due to high investor hopes for an oral weight loss drug the company is developing. In addition, Viking's new tablets are considered to have significant market potential, which could attract acquisition interest from large pharmaceutical companies. William Blair analyst Andy Hsieh said: "Viking's diet drugs are working better than everyone expected, which increases the likelihood of a big Pharma acquisition of Viking. While we acknowledge that it is risky to base investment decisions on the prospect of future acquisitions, the likelihood is considerable."
Analysts point out that the launch of Viking and Astrazeneca's oral pills has intensified competition in the diet drug market between large pharmaceutical companies and small biotech companies. As drug companies scramble to come up with weight-loss pills that appeal to more people, they are all vying for a piece of a huge market that is expected to reach $130 billion by the end of the century.
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
“Amputation or Strategic Retreat?”: Shell’s Six-Year Chemical Losses and the Quiet Unwinding of an Empire
-
LG Chem Enters Semiconductor Stripper Market for the First Time, Cutting Process Time by 50%
-
Kraton Announces Strategic Plan to Streamline Polymer Operations in Berre, France
-
Saudi Aramco’s 400,000 bpd Jazan Refinery Shuts After Attack
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
Coal Price Surge Coupled with El Niño Drives Urea Up by RMB 100/Ton in a Single Day
-
Hormuz Sees at Least 12 Vessel Incidents in One Week as Traffic Falls to Two-Month Low
-
Crude Tanker Freight From the Americas to Asia Tops $80 Million per Voyage Amid Global Shipping Crunch
-
Japan Extends Bisphenol A Anti-Dumping Probe, Prolonging Uncertainty for Korean and Taiwanese Suppliers
-
Sulfur Price Hits 7,633 CNY/Ton, Up Nearly Sixfold in a Year and a Half; Domestic Refining Giants Halt New Orders Due to Tight Supply
Recommend Reading
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
China’s Chemical “Spring Surge”: 68.8% of Products Rising—Real Recovery or Just a Pre-Festival Mirage?
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Polyethylene Supply and Demand Imbalance in 2025, Excess Situation Unchanged in 2026
-
This Week's Acetic Acid Market Trend Weakens in China
-
Premium Global Chemical Sourcing Requests (9-12Apr, 2026)
-
Premium Global Chemical Sourcing Requests (29 Dec, 2025- 2 Jan, 2026)
-
This Week's Isopropyl Alcohol Market Prices Decline (5.11-5.15) in China